Total Payments
$2,702
2024 Payments
$575.45
Companies
32
Transactions
95
Medicare Patients
1,405
Medicare Billing
$282,080
Payment Breakdown by Category
Food & Beverage$2,401 (88.9%)
Consulting$300.00 (11.1%)
Education$0.72 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,401 | 93 | 88.9% |
| Consulting Fee | $300.00 | 1 | 11.1% |
| Education | $0.72 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Aspira Women's Health Inc | $363.10 | 4 | $0 (2024) |
| Merck Sharp & Dohme LLC | $320.44 | 15 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $264.80 | 6 | $0 (2024) |
| Clovis Oncology, Inc. | $227.45 | 9 | $0 (2022) |
| GlaxoSmithKline, LLC. | $187.46 | 8 | $0 (2024) |
| Stryker Corporation | $175.00 | 1 | $0 (2022) |
| ABBVIE INC. | $157.26 | 7 | $0 (2024) |
| Genmab U.S., Inc. | $144.03 | 6 | $0 (2024) |
| TESARO, Inc. | $112.28 | 4 | $0 (2019) |
| Eisai Inc. | $96.66 | 4 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $575.45 | 22 | Merck Sharp & Dohme LLC ($127.35) |
| 2023 | $346.90 | 14 | Genmab U.S., Inc. ($69.03) |
| 2022 | $554.11 | 14 | Stryker Corporation ($175.00) |
| 2021 | $80.15 | 3 | Aspira Women's Health Inc ($37.08) |
| 2020 | $365.92 | 4 | Aspira Women's Health Inc ($300.00) |
| 2019 | $492.12 | 23 | Clovis Oncology, Inc. ($180.83) |
| 2018 | $149.70 | 8 | Merck Sharp & Dohme Corporation ($36.78) |
| 2017 | $137.21 | 7 | TESARO, Inc. ($34.17) |
All Payment Transactions
95 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/13/2024 | Merck Sharp & Dohme LLC | LYNPARZA (Biological) | Food and Beverage | In-kind items and services | $34.74 | General |
| Category: ONCOLOGY | ||||||
| 11/23/2024 | ABBVIE INC. | ELAHERE (Drug) | Food and Beverage | In-kind items and services | $25.17 | General |
| Category: ONCOLOGY | ||||||
| 11/18/2024 | Novartis Pharmaceuticals Corporation | MEKINIST (Drug) | Food and Beverage | In-kind items and services | $29.43 | General |
| Category: Oncology | ||||||
| 11/14/2024 | VERTEX PHARMACEUTICALS INCORPORATED | — | Food and Beverage | In-kind items and services | $17.12 | General |
| 11/07/2024 | Merck Sharp & Dohme LLC | LYNPARZA (Biological) | Food and Beverage | In-kind items and services | $22.63 | General |
| Category: ONCOLOGY | ||||||
| 11/01/2024 | Tempus AI, Inc | XT CDX (Device) | Food and Beverage | In-kind items and services | $21.63 | General |
| Category: NONE | ||||||
| 10/11/2024 | GlaxoSmithKline, LLC. | JEMPERLI (Biological), ZEJULA | Food and Beverage | In-kind items and services | $25.27 | General |
| Category: ONCOLOGY | ||||||
| 09/20/2024 | Novartis Pharmaceuticals Corporation | MEKINIST (Drug) | Food and Beverage | In-kind items and services | $30.97 | General |
| Category: Oncology | ||||||
| 07/11/2024 | Genmab U.S., Inc. | Tivdak (Drug) | Food and Beverage | In-kind items and services | $28.53 | General |
| Category: Oncology | ||||||
| 06/21/2024 | GlaxoSmithKline, LLC. | ZEJULA (Drug), JEMPERLI | Food and Beverage | In-kind items and services | $26.99 | General |
| Category: ONCOLOGY | ||||||
| 06/14/2024 | Merck Sharp & Dohme LLC | LYNPARZA (Biological) | Food and Beverage | In-kind items and services | $24.22 | General |
| Category: ONCOLOGY | ||||||
| 05/01/2024 | Cumberland Pharmaceuticals, Inc. | SANCUSO (Drug) | Food and Beverage | In-kind items and services | $17.35 | General |
| Category: ONCOLOGY | ||||||
| 04/24/2024 | Aspira Women's Health Inc | OVA1 (Device) | Food and Beverage | In-kind items and services | $7.23 | General |
| Category: OB/GYN | ||||||
| 04/05/2024 | Myriad Genetic Laboratories, Inc. | MYRISK (Device) | Food and Beverage | In-kind items and services | $23.42 | General |
| Category: ONCOLOGY | ||||||
| 04/03/2024 | GlaxoSmithKline, LLC. | JEMPERLI (Biological), ZEJULA | Food and Beverage | In-kind items and services | $21.53 | General |
| Category: ONCOLOGY | ||||||
| 03/15/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $67.50 | General |
| 02/23/2024 | ABBVIE INC. | ELAHERE (Drug) | Food and Beverage | In-kind items and services | $29.96 | General |
| Category: ONCOLOGY | ||||||
| 02/16/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $20.29 | General |
| Category: ONCOLOGY | ||||||
| 02/10/2024 | Davol Inc. | ARISTA AH FlexiTip (Device) | Food and Beverage | In-kind items and services | $20.60 | General |
| Category: Surgery | ||||||
| 02/02/2024 | Genmab U.S., Inc. | Tivdak (Drug) | Food and Beverage | In-kind items and services | $23.57 | General |
| Category: Oncology | ||||||
| 01/12/2024 | GlaxoSmithKline, LLC. | JEMPERLI (Biological) | Food and Beverage | In-kind items and services | $31.83 | General |
| Category: ONCOLOGY | ||||||
| 01/03/2024 | Merck Sharp & Dohme LLC | LYNPARZA (Biological) | Food and Beverage | In-kind items and services | $25.47 | General |
| Category: ONCOLOGY | ||||||
| 12/16/2023 | ImmunoGen, Inc. | Elahere (Biological) | Food and Beverage | In-kind items and services | $23.08 | General |
| Category: Oncology | ||||||
| 12/07/2023 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | Cash or cash equivalent | $24.61 | General |
| Category: Oncology | ||||||
| 11/27/2023 | Genmab U.S., Inc. | Tivdak (Drug) | Food and Beverage | In-kind items and services | $20.48 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 361 | 442 | $207,329 | $64,713 |
| 2022 | 14 | 422 | 828 | $460,420 | $110,712 |
| 2021 | 9 | 292 | 413 | $144,036 | $55,581 |
| 2020 | 10 | 330 | 448 | $138,611 | $51,074 |
Total Patients
1,405
Total Services
2,131
Medicare Billing
$282,080
Procedure Codes
42
All Medicare Procedures & Services
42 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 58571 | Removal of uterus, tubes, and/or ovaries through abdomen using an endoscope, 250.0 g or less | Facility | 2023 | 24 | 24 | $67,454 | $17,665 | 26.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 33 | 76 | $25,040 | $11,088 | 44.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 68 | 86 | $20,210 | $8,480 | 42.0% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 47 | 47 | $22,250 | $8,173 | 36.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 101 | 121 | $18,755 | $7,457 | 39.8% |
| 38570 | Biopsy and removal of lymph nodes of abdominal cavity using an endoscope | Facility | 2023 | 20 | 20 | $29,000 | $4,300 | 14.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 25 | 25 | $9,040 | $3,313 | 36.6% |
| 38900 | Imaging of lymph nodes during surgery | Facility | 2023 | 19 | 19 | $13,300 | $3,251 | 24.4% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2023 | 24 | 24 | $2,280 | $986.40 | 43.3% |
| J2506 | Injection, pegfilgrastim, excludes biosimilar, 0.5 mg | Office | 2022 | 13 | 288 | $232,686 | $37,324 | 16.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 42 | 104 | $31,200 | $15,591 | 50.0% |
| 58571 | Removal of uterus, tubes, and/or ovaries through abdomen using an endoscope, 250.0 g or less | Facility | 2022 | 19 | 19 | $50,544 | $14,273 | 28.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 71 | 98 | $23,030 | $10,206 | 44.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 88 | 117 | $18,135 | $8,036 | 44.3% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 33 | 33 | $14,025 | $5,536 | 39.5% |
| 38570 | Biopsy and removal of lymph nodes of abdominal cavity using an endoscope | Facility | 2022 | 21 | 21 | $30,450 | $5,310 | 17.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 34 | 34 | $10,880 | $4,455 | 40.9% |
| 38900 | Imaging of lymph nodes during surgery | Facility | 2022 | 23 | 23 | $16,100 | $4,098 | 25.5% |
| 58558 | Biopsy of lining of uterus and/or removal of polyp using an endoscope | Facility | 2022 | 14 | 14 | $25,200 | $2,754 | 10.9% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2022 | 26 | 26 | $2,470 | $1,099 | 44.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 12 | 12 | $2,820 | $1,054 | 37.4% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 12 | 14 | $1,330 | $672.21 | 50.5% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 14 | 25 | $1,550 | $304.55 | 19.6% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 33 | 110 | $31,536 | $16,617 | 52.7% |
| 58571 | Abdominal removal of uterus (250 grams or less) with removal of tubes and/or ovaries using an endoscope | Facility | 2021 | 12 | 12 | $32,400 | $9,290 | 28.7% |
About Dr. David Holtz, MD
Dr. David Holtz, MD is a Gynecologic Oncology healthcare provider based in Wynnewood, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/25/2006. The National Provider Identifier (NPI) number assigned to this provider is 1215907084.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Holtz, MD has received a total of $2,702 in payments from pharmaceutical and medical device companies, with $575.45 received in 2024. These payments were reported across 95 transactions from 32 companies. The most common payment nature is "Food and Beverage" ($2,401).
As a Medicare-enrolled provider, Holtz has provided services to 1,405 Medicare beneficiaries, totaling 2,131 services with total Medicare billing of $282,080. Data is available for 4 years (2020–2023), covering 42 distinct procedure/service records.
Ad
Practice Information
- Specialty Gynecologic Oncology
- Location Wynnewood, PA
- Active Since 01/25/2006
- Last Updated 10/01/2015
- Taxonomy Code 207VX0201X
- Entity Type Individual
- NPI Number 1215907084
Products in Payments
- OVA1 (Device) $363.10
- ZEJULA (Drug) $221.11
- KEYTRUDA (Biological) $213.38
- Rubraca (Drug) $213.36
- SPY-PHI SYSTEM (Device) $175.00
- Tivdak (Drug) $121.13
- LYNPARZA (Biological) $107.06
- FARXIGA (Drug) $100.62
- LYNPARZA (Drug) $96.68
- Lenvima (Drug) $96.66
- ARISTA AH FlexiTip (Device) $79.57
- JEMPERLI (Biological) $78.63
- Avastin (Biological) $73.40
- MEKINIST (Drug) $60.40
- ELAHERE (Drug) $55.13
- Elahere (Biological) $52.92
- Neulasta (Biological) $46.72
- Fulphila (Biological) $29.30
- ORILISSA (Drug) $28.16
- LILETTA (Drug) $25.00
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gynecologic Oncology Doctors in Wynnewood
Dr. Charles Dunton, Md, MD
Gynecologic Oncology — Payments: $371,613
Gynecologic Oncology $371,613
Caitlin Farabaugh
Gynecologic Oncology — Payments: $3,230
Gynecologic Oncology $3,230
Dr. Xiaomang Stickles, Md, MD
Gynecologic Oncology — Payments: $1,762
Gynecologic Oncology $1,762
Sudeshna Chatterjee-Paer, M.d, M.D
Gynecologic Oncology — Payments: $1,312
Gynecologic Oncology $1,312
Lauren Turker, M.d, M.D
Gynecologic Oncology — Payments: $548.98
Gynecologic Oncology $548.98